Cargando…
Analysis of Genetic Alterations in Tunisian Patients with Lung Adenocarcinoma
The identification of the mutations that drive lung cancer have furnished new targets for the treatment of non-small cell lung cancer (NSCLC) and led to the development of targeted therapies such as tyrosine kinase inhibitors that are used to combat the molecular changes promoting cancer progression...
Autores principales: | Dhieb, Dhoha, Belguith, Imen, Capelli, Laura, Chiadini, Elisa, Canale, Matteo, Bravaccini, Sara, Yangui, Ilhem, Boudawara, Ons, Jlidi, Rachid, Boudawara, Tahya, Calistri, Daniele, Ammar Keskes, Leila, Ulivi, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627075/ https://www.ncbi.nlm.nih.gov/pubmed/31141932 http://dx.doi.org/10.3390/cells8060514 |
Ejemplares similares
-
Colorectal Cancer Archaeome: A Metagenomic Exploration, Tunisia
por: Mathlouthi, Nour El Houda, et al.
Publicado: (2023) -
Predominance of the Rare EGFR Mutation p.L861Q in Tunisian Patients with Non-Small Cell Lung Carcinoma
por: Abdelmaksoud-Dammak, Rania, et al.
Publicado: (2022) -
Correlation of HER-2 over-expression with clinico-pathological parameters in Tunisian breast carcinoma
por: Ayadi, Lobna, et al.
Publicado: (2008) -
Correlation Between Immunohistochemical Biomarkers Expression and Prognosis of Ovarian Carcinomas in Tunisian Patients
por: Ayadi, Lobna, et al.
Publicado: (2010) -
Isolated left pulmonary artery hypoplasia
por: Touil, Imen, et al.
Publicado: (2020)